Breaking News Instant updates and real-time market news.

2020-12-02 11:16:45 LSPD Lightspeed $57.07 / +4.63 (+8.83%) 11:16 12/02/20 12/02 11:16 12/02/20 11:16	Lightspeed price target raised to C$67 from C$56 at RBC Capital RBC Capital analyst Paul Treiber raised the firm's price target on Lightspeed to C$67 from C$56 and keeps a Sector Perform rating on the shares.	11 Sep
LSPD Lightspeed $57.07 / +4.63 (+8.83%) 12/02/20 BMO Capital Lightspeed price target raised to C$80 from C$62 at BMO Capital 12/02/20 Raymond James Lightspeed price target raised to C$80 from C$61 at Raymond James 12/02/20 CIBC Lightspeed price target raised to C$80 from C$67 at CIBC 12/02/20 Scotiabank Lightspeed price target raised to C$70 from C$56 at Scotiabank

2020-12-02 11:16:45

LSPD

Lightspeed

$57.07 / +4.63 (+8.83%)

11:16

12/02/20

12/02

11:16

12/02/20

11:16

Lightspeed price target raised to C$67 from C$56 at RBC Capital

RBC Capital analyst Paul Treiber raised the firm's price target on Lightspeed to C$67 from C$56 and keeps a Sector Perform rating on the shares.

11
Sep

LSPD Lightspeed

$57.07 / +4.63 (+8.83%)

12/02/20 BMO Capital: Lightspeed price target raised to C$80 from C$62 at BMO Capital

12/02/20 Raymond James: Lightspeed price target raised to C$80 from C$61 at Raymond James

12/02/20 CIBC: Lightspeed price target raised to C$80 from C$67 at CIBC

12/02/20 Scotiabank: Lightspeed price target raised to C$70 from C$56 at Scotiabank

TODAY'S FREE FLY STORIES

Syndicate	Athira Pharma files to sell 4M shares of common stock » 07:41 01/19/21 01/19 07:41 01/19/21 07:41 ATHA Athira Pharma $26.47 / -0.43 (-1.60%) Goldman, Jefferies and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ATHA Athira Pharma $26.47 / -0.43 (-1.60%) 12/14/20 Athira says ATH platform can potentially address several clinical applications 12/14/20 Athira Pharma CEO says timelines 'remained on track' despite COVID 12/14/20 Urgent need remains for Alzheimer's treatment, Athira CEO says 12/14/20 Athira CEO anticipates LIFT-AD trial topline results by end of 2022 ATHA Athira Pharma $26.47 / -0.43 (-1.60%) 10/13/20 Jefferies Athira Pharma initiated with a Buy at Jefferies 10/13/20 JMP Securities Athira Pharma initiated with an Outperform at JMP Securities 10/13/20 Stifel Athira Pharma initiated with a Buy at Stifel 10/13/20 Goldman Sachs Athira Pharma initiated with a Buy at Goldman Sachs ATHA Athira Pharma $26.47 / -0.43 (-1.60%) 11/12/20 Athira Pharma reports Q EPS ($1.12), consensus (25c) 18 Sep
Downgrade	Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley » 07:41 01/19/21 01/19 07:41 01/19/21 07:41 EDIT Editas Medicine $76.07 / +0.19 (+0.25%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 01/11/21 Editas Medicine Chief Scientific Officer Charles Albright, Ph.D to step down 01/11/21 Editas Medicine says FDA clears initiation of EDIT-301 clinical trial 12/21/20 Editas leads gene editing stocks higher with 46% rally to $95.42 12/09/20 Editas Medicine submits IND application for EDIT-301 with FDA EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 01/13/21 Wells Fargo Editas Medicine price target raised to $86 from $69 at Wells Fargo 01/08/21 Raymond James Editas downgraded to Market Perform at Raymond James (Thursday morning) 01/07/21 Raymond James Editas Medicine downgraded to Market Perform from Outperform at Raymond James 12/10/20 Fly Intel: Top five analyst upgrades EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 11/05/20 Editas Medicine reports Q3 EPS 12c, consensus (64c) 08/06/20 Editas Medicine reports Q2 EPS (43c), consensus (79c) 24 Jun EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 08/06/20 Editas Medicine, Beam Therapeutics decline comment to Bloomberg on tie-up rumors EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 12/10/20 Fly Intel: Pre-market Movers 12/09/20 Fly Intel: After-Hours Movers EDIT Editas Medicine $76.07 / +0.19 (+0.25%) 12/21/20 Editas Medicine call volume above normal and directionally bullish 12/17/20 Largest borrow rate increases among liquid names 12/14/20 Editas Medicine call volume above normal and directionally bullish 10/30/20 Largest borrow rate increases among liquid names
Hot Stocks	CorVel, ReedGroup partner to offer integrated disability management » 07:41 01/19/21 01/19 07:41 01/19/21 07:41 CRVL CorVel $105.12 / -0.41 (-0.39%) The companies said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News CRVL CorVel $105.12 / -0.41 (-0.39%) 01/12/21 CorVel, 1health partner for at-home COVID-19 testing 10/13/20 CorVel Chairman Gordon Clemons sold over $268K in company shares
Hot Stocks	Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer » 07:40 01/19/21 01/19 07:40 01/19/21 07:40 FREQ FREQ / + , CERE Cerevel Therapeutics $14.46 / -0.59 (-3.92%) Frequency Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FREQ CERE FREQ FREQ / + 12/01/20 Frequency Therapeutics names Peter Pfreundschuh as new CFO 11/16/20 Frequency Therapeutics provides update on FX-322 study 09/22/20 Frequency Therapeutics completes patient enrollment of FX-322 09/13/20 Frequency presents results from longer-term durability study of FX-322 CERE Cerevel Therapeutics $14.46 / -0.59 (-3.92%) 12/08/20 Cerevel Therapeutics appoints Ruth McKernan to board of directors 10/30/20 Cerevel Therapeutics doses first patients in Phase 3 trials of tavapadon 10/28/20 Cerevel Therapeutics debuts as publicly-traded neuroscience company FREQ CERE FREQ FREQ / + 12/22/20 B. Riley Securities Frequency Therapeutics initiated with a Buy at B. Riley Securities 12/16/20 Oppenheimer Frequency Therapeutics price target raised to $48 from $36 at Oppenheimer 07/13/20 Oppenheimer Frequency Therapeutics initiated with an Outperform at Oppenheimer 05/18/20 JPMorgan JPMorgan downgrades Frequency Therapeutics on unclear data timelines CERE Cerevel Therapeutics $14.46 / -0.59 (-3.92%) 12/10/20 Goldman Sachs Cerevel Therapeutics initiated with a Buy at Goldman Sachs 11/23/20 Jefferies Cerevel Therapeutics initiated with a Buy at Jefferies 11/09/20 Fly Intel: Top five analyst initiations 11/09/20 Stifel Cerevel Therapeutics initiated with a Buy at Stifel FREQ FREQ FREQ / + 11/16/20 Frequency Therapeutics reports Q3 EPS (16c), consensus (28c) 08/12/20 Frequency Therapeutics reports Q2 EPS (19c), consensus (18c)
Downgrade	Peloton downgraded to Sell from Neutral at UBS » 07:40 01/19/21 01/19 07:40 01/19/21 07:40 PTON Peloton / + UBS analyst Eric Sheridan… UBS analyst Eric Sheridan downgraded Peloton Interactive to Sell from Neutral with a price target of $124, up from $115. The stock is "emblematic of a market that values growth over any semblance of valuation that can be justified" on a multiple year view based on fundamentals, Sheridan tells investors in a research note. The analyst thinks investors "need to be wary of the rising trend of bull market optimism" in a handful of businesses that have been either COVID-19 "beneficiaries" or have come to the public markets over the last 18 months. He sees a negative risk/reward skew for Peloton shares at current levels. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PTON Peloton / + 12/21/20 Peloton jumps 5% to $152.49 after agreeing to acquire Precor for $420M 12/21/20 Peloton to acquire Precor for $420M 12/09/20 Peloton grows Plano campus by more than 100,000 square feet 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 PTON Peloton / + 01/08/21 Fly Intel: Top five analyst initiations 01/08/21 Gordon Haskett Peloton initiated with a Buy at Gordon Haskett 01/05/21 Stifel Stifel adds Vroom to Select List, removes Buy-rated Peloton 01/04/21 Barclays Peloton assumed with an Overweight at Barclays PTON Peloton / + 11/05/20 Peloton sees Q2 revenue $1B, consensus $939.04M 11/05/20 Peloton reports Q1 EPS 20c, consensus 11c 11/05/20 Notable companies reporting after market close 09/10/20 Peloton sees FY21 revenue $3.5B-$3.65B, consensus $2.72B PTON Peloton / + 01/17/21 Peloton rapid rise threatened by slow delivery, NY Times says 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says 11/25/20 Peloton shipping delays may benefit Nautilus, WSJ reports 10/05/20 NordicTrack owner valued at over $7B in new funding round, Bloomberg says PTON Peloton / + 12/22/20 Fly Intel: Pre-market Movers 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers 11/06/20 Fly Intel: Pre-market Movers PTON Peloton / + 09/23/20 Unusual put flow in option market yesterday 09/22/20 Peloton put seller rolls position from Jan to April 09/11/20 Notable open interest changes for September 11th 09/11/20 Unusual call flow in option market yesterday

General news	Treasury Market Outlook: U.S. equity futures are reopening with a bullish tone » 07:40 01/19/21 01/19 07:40 01/19/21 07:40 Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Gilat Satellite awarded contracts for cellular backhaul projects in Mexico » 07:39 01/19/21 01/19 07:39 01/19/21 07:39 GILT Gilat Satellite $7.32 / -0.17 (-2.27%) Gilat Satellite Networks… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals GILT Gilat Satellite $7.32 / -0.17 (-2.27%) 01/11/21 Gilat Satellite awarded multimillion dollar managed service contract from Globe 01/05/21 Gilat Satellite obtains tax ruling with respect to 63c per share dividend 12/30/20 Gilat Satellite appoints Bosmat Halpern as CFO 12/30/20 Gilat Satellite declares cash dividend of 63c per share GILT Gilat Satellite $7.32 / -0.17 (-2.27%) 08/31/20 Gilat Satellite reports Q2 adj. EPS (6c) vs. 9c last year GILT Gilat Satellite $7.32 / -0.17 (-2.27%) 09/08/20 Gilat granted temporary restraining order in fight with Comtech, Bloomberg says 09/08/20 Gilat granted temporary restraining order in fight with Comtech, Bloomberg says
Downgrade	Fiverr downgraded to Sell from Neutral at UBS » 07:39 01/19/21 01/19 07:39 01/19/21 07:39 FVRR Fiverr $267.03 / -3.195 (-1.18%) UBS analyst Eric Sheridan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options FVRR Fiverr $267.03 / -3.195 (-1.18%) 11/19/20 Fiverr announces expansion into Latin America 11/11/20 Fiverr rises 14.5% 11/11/20 Fiverr rises 10.2% 08/05/20 Fiverr sees Q3 revenue $48M-$49M, consensus $37.94M FVRR Fiverr $267.03 / -3.195 (-1.18%) 01/12/21 Citi Fiverr price target raised to $270 from $185 at Citi 12/21/20 Goldman Sachs Fiverr initiated with a Buy at Goldman Sachs 11/20/20 Needham Fiverr price target raised to $210 from $180 at Needham 11/18/20 BTIG Upwork price target raised to $42 from $27 at BTIG FVRR Fiverr $267.03 / -3.195 (-1.18%) 10/28/20 Fiverr raises FY20 revenue view to $186M-$187M from $177.5M-$179.5M 10/28/20 Fiverr sees Q4 revenue $52.4M-$53.4M, consensus $49.72M 10/28/20 Fiverr reports Q3 EPS 13c, consensus 8c 08/05/20 Fiverr raises FY20 revenue guidance to $177.5M-$179.5M, consensus $148.19M 29 May FVRR Fiverr $267.03 / -3.195 (-1.18%) 12/16/20 Facebook building marketplace rival to Angi, Information reports 02/18/21 Fiverr - FVRR FVRR Fiverr $267.03 / -3.195 (-1.18%) 09/01/20 Largest borrow rate increases among liquid names
Downgrade	Chewy downgraded to Sell from Neutral at UBS » 07:39 01/19/21 01/19 07:39 01/19/21 07:39 CHWY Chewy $108.05 / -6.57 (-5.73%) UBS analyst Eric Sheridan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CHWY Chewy $108.05 / -6.57 (-5.73%) 12/22/20 GameStop jumps over 25% after Chewy co-founder Cohen raises activist stake 12/15/20 Chewy's Star sells 30,000 class A common shares 12/08/20 Chewy CEO: We are surprising and delighting customers 12/08/20 Chewy reports Q3 active customers up 39.8% at 17,788 CHWY Chewy $108.05 / -6.57 (-5.73%) 01/13/21 Credit Suisse Chewy price target raised to $121 from $104 at Credit Suisse 01/04/21 Barclays Chewy assumed with an Equal Weight at Barclays 12/18/20 William Blair Chewy share growth should stabilize at 20%-25%, says William Blair 12/17/20 Needham Chewy price target raised to $110 from $90 at Needham CHWY Chewy $108.05 / -6.57 (-5.73%) 12/08/20 Chewy raises FY20 revenue view to $7.04B-$7.06B from $6.775B-$6.825B 12/08/20 Chewy sees Q4 revenue $1.94B-$1.96B, consensus $1.79B 12/08/20 Chewy reports Q3 EPS (8c), consensus (13c) 12/08/20 Notable companies reporting after market close 17 Sep CHWY Chewy $108.05 / -6.57 (-5.73%) 01/16/21 GameStop stock double last week, challenges remain, Barron's says 11/16/20 Chewyco-founder Ryan Cohen wants 'tech-centric' makeover for GameStop, WSJ says 09/22/20 GameStop spikes after investor plans to make it Amazon rival, Bloomberg says CHWY Chewy $108.05 / -6.57 (-5.73%) 12/08/20 Fly Intel: After-Hours Movers 10/15/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: After-Hours Movers CHWY Chewy $108.05 / -6.57 (-5.73%) 12/15/20 Chewy call volume above normal and directionally bullish 12/08/20 Chewy options imply 14.9% move in share price post-earnings 12/07/20 Unusually active option classes on open December 7th 10/28/20 Unusually active option classes on open October 28th
Hot Stocks	Brickell announces Japan Phase 3 study results for sofpironium bromide gel » 07:38 01/19/21 01/19 07:38 01/19/21 07:38 BBI Brickell Biotech $1.10 / +0.03 (+2.80%) Brickell Biotech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events BBI Brickell Biotech $1.10 / +0.03 (+2.80%) 12/07/20 Brickell Biotech doses first patient in second U.S. Phase 3 study 11/18/20 Brickell Biotech announces Japan launch date for sofpironium bromide gel, 5% 10/06/20 Brickell Biotech initiates U.S. Phase 3 program of sofpironium bromide gel, 15% 09/25/20 Brickell says Kaken receives approval of sofpironium bromide gel in Japan BBI Brickell Biotech $1.10 / +0.03 (+2.80%) 09/25/20 Lake Street Approval in Japan validating for Brickell Biotech, says Lake Street 08/28/20 Lake Street Brickell Biotech initiated with a Buy at Lake Street 08/25/20 Oppenheimer Brickell Biotech initiated with an Outperform at Oppenheimer 23 Oct 18 Jun 03/15/21 33rd Annual Roth Virtual Conference

Hot Stocks	Heat Biologics commences manufacturing process for ZVX-60 » 07:37 01/19/21 01/19 07:37 01/19/21 07:37 HTBX Heat Biologics $6.36 / +0.15 (+2.42%) Heat Biologics announces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals HTBX Heat Biologics $6.36 / +0.15 (+2.42%) 01/11/21 Heat Biologics promotes William Ostrander to CFO 12/16/20 Heat Biologics completes its gp96-based COVID-19 vaccine cell line 12/10/20 Heat Biologics announces planned reverse stock split at a ratio of 1-for-7 10/07/20 Heat Biologics issued new patent for gp96 platform with ICOSL HTBX Heat Biologics $6.36 / +0.15 (+2.42%) 12/24/20 B. Riley Securities Heat Biologics transferred with a Buy at B. Riley Securities 10/14/20 Fly Intel: Top five analyst initiations 10/14/20 B. Riley Securities B. Riley sees 200% upside in 'value vaccine play' Heat Biologics 10/14/20 B. Riley Securities Heat Biologics initiated with a Buy at B. Riley Securities HTBX Heat Biologics $6.36 / +0.15 (+2.42%) 11/09/20 Heat Biologics reports Q3 EPS (6c), consensus (3c) HTBX Heat Biologics $6.36 / +0.15 (+2.42%) 08/20/20 Heat Biologics shifts to develop LT immunity vaccine for COVID, CBS 17 says
Hot Stocks	Ashland to acquire personal care business from Schulke & Mayr for EUR262.5M » 07:37 01/19/21 01/19 07:37 01/19/21 07:37 ASH Ashland $84.99 / -1.33 (-1.54%) , EQT EQT Corporation $18.50 / +0.59 (+3.29%) Ashland Global Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options ASH EQT ASH Ashland $84.99 / -1.33 (-1.54%) 07/27/20 Ashland to sell maleic anhydride facility for $100M EQT EQT Corporation $18.50 / +0.59 (+3.29%) 01/13/21 U.S. Well Services, EQT finalize long-term electric fracturing contracts 01/05/21 EQT Corporation reports year-end total proved reserves of 19.8 Tcfe, up 13% 10/27/20 EQT Corporation to acquire Chevron assets in Appalachian Basin for $735M 10/22/20 CNX Resources rises after Bloomberg reports on EQT takeover interest ASH EQT ASH Ashland $84.99 / -1.33 (-1.54%) 07:18 Today Deutsche Bank Ashland named 'Catalyst Call: Buy Idea' at Deutsche Bank 10/09/20 Deutsche Bank Deutsche initiates 'Buy Catalyst Call' on Ashland ahead of results 09/22/20 Evercore ISI Ashland initiated with an In Line at Evercore ISI 08/24/20 JPMorgan Ashland price target raised to $75 from $62 at JPMorgan EQT EQT Corporation $18.50 / +0.59 (+3.29%) 01/11/21 Mizuho EQT Corporation price target lowered to $19 from $28 at Mizuho 12/15/20 Fly Intel: Top five analyst initiations 12/15/20 BofA EQT Corporation initiated with a Buy at BofA 12/08/20 JPMorgan EQT Corporation downgraded to Neutral with $17 target at JPMorgan ASH EQT ASH Ashland $84.99 / -1.33 (-1.54%) 11/10/20 Ashland reports Q4 adjusted EPS $1.25, consensus 75c EQT EQT Corporation $18.50 / +0.59 (+3.29%) 10/22/20 EQT Corporation reports Q3 adj. EPS (15c), consensus (24c) 07/27/20 EQT Corporation reports Q2 adj. EPS (18c), consensus (14c) 17 Nov 28 Oct EQT EQT EQT Corporation $18.50 / +0.59 (+3.29%) 10/22/20 EQT pursuing acquisition of CNX Resources, Bloomberg reports 10/22/20 EQT recently made takeover proposal to CNX Resources, Bloomberg says 10/22/20 EQT said to pursue acquisition of CNX Resources, Bloomberg reports 01/28/21 Ashland Global Holdings Inc EQT EQT EQT Corporation $18.50 / +0.59 (+3.29%) 01/15/21 Early notable gainers among liquid option names on January 15th 01/12/21 Early notable gainers among liquid option names on January 12th 01/05/21 Early notable gainers among liquid option names on January 5th 12/15/20 Early notable gainers among liquid option names on December 15th
Upgrade	Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year' » 07:35 01/19/21 01/19 07:35 01/19/21 07:35 GILD Gilead $63.35 / +0.95 (+1.52%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GILD Gilead $63.35 / +0.95 (+1.52%) 01/12/21 Gilead, Vir Biotechnology establish collaboration for chronic HBV 01/12/21 Gilead, Vir collaborate to explore combination strategies for HBV cure 01/06/21 Kite, Oxford BioTherapeutics enter research collaboration 12/16/20 Kite granted conditional marketing authorization for Tecartus from EC GILD Gilead $63.35 / +0.95 (+1.52%) 06:01 Today Morgan Stanley Gilead upgraded to Overweight from Equal Weight at Morgan Stanley 01/11/21 Piper Sandler Piper says hard for Gilead investors to ascribe long-term value to Veklury 01/04/21 Guggenheim Gilead upgraded to Buy from Neutral at Guggenheim 12/22/20 Citi Gilead price target lowered to $72 from $75 at Citi GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Gilead raises FY20 adjusted EPS view to $6.98 - $7.08 from $6.25 - $6.60 10/28/20 Gilead sees core business gradually recovering in Q4 and into 1H21 10/28/20 Gilead narrows FY20 adjusted EPS view to $6.25-$6.60 from $6.25-$7.65 10/28/20 Gilead Sciences reports Q3 adjusted EPS $2.11, consensus $1.95 GILD Gilead $63.35 / +0.95 (+1.52%) 11/19/20 WHO urges doctors not to use Gilead's remdesivir for coronavirus, Bloomberg says 10/15/20 WHO study says Gilead's remdesivir has little impact on COVID mortality, FT says 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/12/20 Gilead near deal to buy Immunomedics for over $20B, WSJ reports GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Gilead call volume above normal and directionally bullish 12/31/20 Unusually active option classes on open December 31st 12/01/20 Gilead call volume above normal and directionally bullish 11/23/20 Gilead put volume heavy and directionally bearish
Options	Unusual call flow in option market yesterday » 07:35 01/19/21 01/19 07:35 01/19/21 07:35 SLQT SelectQuote $23.55 / +0.98 (+4.34%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SLQT SelectQuote $23.55 / +0.98 (+4.34%) 09/01/20 SelectQuote announces first partnership with primary care provider Iora Health 07/24/20 SelectQuote falls -19.1% 07/24/20 SelectQuote falls -11.5% SLQT SelectQuote $23.55 / +0.98 (+4.34%) 10/06/20 Credit Suisse Walmart entry shows attractiveness of insurance market, says Credit Suisse 10/06/20 Citi Walmart entry a 'significant competitive threat' to eHealth, says Citi 09/08/20 Credit Suisse SelectQuote price target lowered to $31 from $38 at Credit Suisse 07/01/20 SVB Leerink SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform SLQT SelectQuote $23.55 / +0.98 (+4.34%) 11/05/20 SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M 11/05/20 SelectQuote reports Q1 EPS 1c, consensus (4c) 09/09/20 SelectQuote sees FY21 revenue $775M-$815M, consensus $756.96M 09/09/20 SelectQuote reports Q4 EPS 13c, consensus 3c 21 May SLQT SelectQuote $23.55 / +0.98 (+4.34%) 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers SLQT SelectQuote $23.55 / +0.98 (+4.34%) 01/15/21 SelectQuote call buyer as shares jump
Recommendations	AMN Healthcare price target raised to $81 from $72 at BMO Capital » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 AMN AMN Healthcare $72.10 / +0.075 (+0.10%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings AMN AMN Healthcare $72.10 / +0.075 (+0.10%) 11/06/20 Truist AMN Healthcare price target raised to $78 from $68 at Truist 11/06/20 Credit Suisse AMN Healthcare price target raised to $76 from $63 at Credit Suisse 10/08/20 BofA AMN Healthcare initiated with a Buy at BofA 08/07/20 BMO Capital AMN Healthcare price target raised to $65 from $50 at BMO Capital AMN AMN Healthcare $72.10 / +0.075 (+0.10%) 01/11/21 AMN Healthcare sees Q4 revenue $623M-$628M, consensus $584.45M 11/05/20 AMN Healthcare sees Q4 revenue $575M-$585M, consensus $549.71M 11/05/20 AMN Healthcare reports Q3 adjusted EPS 82c, consensus 69c 10/29/20 Notable companies reporting after market close

Earnings	Kforce expects EPS to exceed 78c per share, consensus 75c » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 KFRC Kforce $42.70 / -1.28 (-2.91%) Sees revenue exceeding… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly KFRC Kforce $42.70 / -1.28 (-2.91%) 01/04/21 Sidoti Kforce upgraded to Buy from Neutral at Sidoti 08/11/20 Truist Kforce price target raised to $35 from $30 at Truist 08/11/20 William Blair Kforce upgraded to Outperform from Market Perform at William Blair 05/28/20 Sidoti Kforce downgraded to Neutral from Buy at Sidoti KFRC Kforce $42.70 / -1.28 (-2.91%) 11/02/20 Kforce sees Q4 EPS 70c-78c,consensus 60c 11/02/20 Kforce reports Q3 EPS 89c, consensus 81c 09/21/20 Kforce raises Q3 EPS greater than 82c per share, consensus 76c 08/10/20 Kforce sees Q3 EPS 72c-80c, consensus 40c KFRC Kforce $42.70 / -1.28 (-2.91%) 09/21/20 Fly Intel: After-Hours Movers 08/10/20 Fly Intel: After-Hours Movers
Hot Stocks	Pembina Pipeline announces binding open season » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) Pembina Pipeline… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) 01/13/21 CIBC Pembina Pipeline price target raised to C$40 from C$38 at CIBC 12/15/20 BMO Capital Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital 11/30/20 Wells Fargo Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo 11/19/20 Canaccord Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord 02/26/21 Pembina Pipeline - PBA
Hot Stocks	Veritone, Base Media Cloud announce six-year agreement » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 VERI Veritone $38.75 / -1.99 (-4.88%) Veritone with Base Media… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone $38.75 / -1.99 (-4.88%) 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison 12/03/20 Veritone reports achievement of AWS Public Safety & Disaster Response Competency 11/19/20 Veritone receives three new patents for battery control technology VERI Veritone $38.75 / -1.99 (-4.88%) 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel 11/19/20 Roth Capital Veritone price target raised to $20 from $18 at Roth Capital 10/06/20 Roth Capital Veritone energy suite adds to platform's use cases, says Roth Capital VERI Veritone $38.75 / -1.99 (-4.88%) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 11/09/20 Veritone reports Q3 EPS (15c), consensus (20c) 08/10/20 Veritone sees Q3 revenue $14.2M-$14.6M, consensus $13.3M 08/10/20 Veritone reports Q2 adjusted EPS (21c), consensus (23c) 03 Dec VERI Veritone $38.75 / -1.99 (-4.88%) 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference VERI Veritone $38.75 / -1.99 (-4.88%) 12/07/20 Largest borrow rate increases among liquid names
Initiation	Skillz platform accelerates, Canacord initiates with Buy » 07:33 01/19/21 01/19 07:33 01/19/21 07:33 SKLZ Skillz $24.81 / -1.23 (-4.72%) As reported previously,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SKLZ Skillz $24.81 / -1.23 (-4.72%) 06:37 Today Canaccord Skillz initiated with a Buy at Canaccord 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Wells Fargo Skillz initiated with an Equal Weight at Wells Fargo 01/12/21 Wedbush Skillz initiated with an Outperform at Wedbush
Hot Stocks	Accuray reports data from phase II trial using TomoTherapy System » 07:32 01/19/21 01/19 07:32 01/19/21 07:32 ARAY Accuray $4.76 / -0.2 (-4.03%) Accuray announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARAY Accuray $4.76 / -0.2 (-4.03%) 01/05/21 Accuray receives FDA clearance for its Helical kVCT Imaging 11/18/20 Accuray, DHL Supply Chain enter logistics partnership 11/12/20 Accuray director Whitters buys 50,000 shares 10/28/20 Accuray signs agreement with Brainlab to expand Cyberknife treatment ARAY Accuray $4.76 / -0.2 (-4.03%) 01/07/21 Fly Intel: Top five analyst initiations 01/07/21 Northland Accuray initiated with an Outperform at Northland 09/28/20 Lake Street CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street 09/18/20 Cowen New CMS model should provide tailwind for Accuray, says Cowen ARAY Accuray $4.76 / -0.2 (-4.03%) 10/29/20 Accuray reports Q1 EPS 0c, consensus (7c) 08/13/20 Accuray not providing FY21 guidance 08/13/20 Accuray reports Q4 EPS (1c), consensus (2c) ARAY Accuray $4.76 / -0.2 (-4.03%) 10/29/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: After-Hours Movers 01/27/21 Accuray - ARAY

Earnings	FMC Corporation cuts Q4 revenue view to about $1.15B from $1.23B-$1.29B » 07:32 01/19/21 01/19 07:32 01/19/21 07:32 FMC FMC Corporation $120.03 / -1.69 (-1.39%) Q4 consensus $1.26B. FMC… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FMC FMC Corporation $120.03 / -1.69 (-1.39%) 12/02/20 FMC Corporation raises dividend by 9% to 48c per share 11/02/20 FMC Corporation sees FY20 free cash flow $475M-$525M 10/26/20 FMC Corporation names Dr. Karen Totland as chief sustainability officer 08/20/20 FMC Corporation partnering with Zymergen for crop protection technology FMC FMC Corporation $120.03 / -1.69 (-1.39%) 11/20/20 Fly Intel: Top five analyst initiations 11/20/20 Bernstein FMC Corporation initiated with a Market Perform at Bernstein 11/18/20 BMO Capital FMC Corporation price target raised to $124 from $120 at BMO Capital 11/18/20 KeyBanc FMC Corporation price target raised to $137 from $121 at KeyBanc FMC FMC Corporation $120.03 / -1.69 (-1.39%) 11/02/20 FMC Corporation sees Q4 adjusted EPS $1.70-$1.82, consensus $1.82 11/02/20 FMC Corporation narrows FY20 adjusted EPS view to $6.45 -$6.57 from $6.28-$6.62 11/02/20 FMC Corporation reports Q3 adjusted EPS $1.22, consensus $1.11 11/02/20 Notable companies reporting after market close 02/10/21 FMC Corporation - FMC
Recommendations	Snap price target raised to $60 from $40 at KeyBanc » 07:31 01/19/21 01/19 07:31 01/19/21 07:31 SNAP Snap $50.29 / +1.245 (+2.54%) KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SNAP Snap $50.29 / +1.245 (+2.54%) 12/29/20 Snap rises 10.1% 12/17/20 Snap CFO sells 56.8K shares of common stock 12/17/20 Unity, Snap announce partnership to extend advertising, technology reach 12/14/20 FTC seeking data from Facebook, other social media and streaming services SNAP Snap $50.29 / +1.245 (+2.54%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 MoffettNathanson Snap upgraded to Buy with $57 price target at MoffettNathanson 01/15/21 MoffettNathanson Snap upgraded to Buy from Neutral at MoffettNathanson 01/12/21 Cowen Snap price target raised to $62 from $45 at Cowen SNAP Snap $50.29 / +1.245 (+2.54%) 10/20/20 Snap says 47%-50% year-over-year revenue growth in Q4 'attainable' 10/20/20 Snap reports Q3 adjusted EPS 1c, consensus (5c) 10/20/20 Notable companies reporting after market close 07/21/20 Snap not providing Q3 revenue, adjusted EBITDA guidance SNAP Snap $50.29 / +1.245 (+2.54%) 01/13/21 Snap to permanently suspend Trump's Snapchat account, Reuters says 01/11/21 Snap confirms acquisition of start-up StreetCred, TechCrunch reports 01/04/21 Google, Snap in advanced discussions to invest in ShareChat, TechCrunch reports 12/14/20 FTC to launch sweeping privacy study of Amazon, Facebook, Axios says SNAP Snap $50.29 / +1.245 (+2.54%) 10/21/20 Pinterest jumps as analysts say buy after Snap earnings beat 10/21/20 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: After-Hours Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 02/23/21 Snap Inc. SNAP Snap $50.29 / +1.245 (+2.54%) 01/11/21 Unusually active option classes on open January 11th 01/07/21 Snap Inc. call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th
Hot Stocks	Federal court dismisses class action lawsuit against 22nd Century » 07:31 01/19/21 01/19 07:31 01/19/21 07:31 XXII 22nd Century $2.77 / -0.05 (-1.77%) 22nd Century Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings XXII 22nd Century $2.77 / -0.05 (-1.77%) 01/11/21 22nd Century to expand VLN Tobacco growing program 12/08/20 22nd Century receives order for 3.6M SPECTRUM variable nicotine cigarettes 11/05/20 22nd Century says 'intensified its proactive efforts' to secure MRTP 10/14/20 22nd Century announces grant of new U.S. patent related to nicotine reduction XXII 22nd Century $2.77 / -0.05 (-1.77%) 11/05/20 22nd Century reports Q3 EPS (3c), one estimate (4c) 08/06/20 22nd Century reports Q2 EPS (4c) vs. (6c) a year ago
Recommendations	Assurant price target raised to $170 from $150 at Truist » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 AIZ Assurant $31.00 / +15 (+9.00%) Truist analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events Options AIZ Assurant $31.00 / +15 (+9.00%) 01/12/21 Assurant announces new $600M share repurchase plan 12/17/20 Assurant acquires EPG Insurance for $43M in cash 11/11/20 Assurant raises quarterly dividend 5% to 66c per share 10/28/20 Assurant acquires HYLA Mobile in $325M transaction AIZ Assurant $31.00 / +15 (+9.00%) 11/02/20 Assurant raises FY20 adj. net income growth view to 17%-21% from 12%-16% 11/02/20 Assurant reports Q3 ops EPS $1.41, consensus $1.00 08/04/20 Assurant sees 2020 adjusted net income up 12%-16% from 2019 08/04/20 Assurant reports Q2 EPS $2.75, consensus $2.09 02/10/21 Assurant - AIZ AIZ Assurant $31.00 / +15 (+9.00%) 08/05/20 Early notable gainers among liquid option names on August 5th
Recommendations	Pinterest price target raised to $86 from $76 at KeyBanc » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 PINS Pinterest / + KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PINS Pinterest / + 12/17/20 Pinterest pledges changes to workplace culture after discrimination settlement 12/01/20 AudioEye announces Rob Ulveling as chief business officer 10/29/20 Pinterest rises 30.2% 10/29/20 Pinterest rises 38.1% PINS Pinterest / + 01/08/21 Baird Pinterest price target raised to $80 from $68 at Baird 01/05/21 Morgan Stanley Pinterest price target raised to $80 from $73 at Morgan Stanley 01/05/21 Morgan Stanley Facebook price target raised to $340 from $315 at Morgan Stanley 12/17/20 Fly Intel: Top five analyst initiations PINS Pinterest / + 10/28/20 Pinterest sees Q4 revenue up 60 from last year 10/28/20 Pinterest reports Q3 EPS 13c, consensus 2c 10/28/20 Notable companies reporting after market close 07/31/20 Pinterest not providing FY20 guidance due to COVID-19 PINS Pinterest / + 12/15/20 Pinterest to pay $22.5M to settle gender discrimination suit, NY Times reports 12/01/20 Pinterest holders sue company over alleged culture of discrimination, Verge says 08/12/20 Former Pinterest COO accuses company of gender bias in suit, NY Times reports PINS Pinterest / + 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers 10/21/20 Pinterest jumps as analysts say buy after Snap earnings beat 10/21/20 Fly Intel: Pre-market Movers PINS Pinterest / + 12/31/20 Pinterest call buyer realizes 4% same-day gains 12/30/20 Pinterest call volume above normal and directionally bullish 12/23/20 Pinterest call volume above normal and directionally bullish 10/30/20 Unusually active option classes on open October 30th

Events

Earnings calls, analyst events, roadshows and more

CMA
Today at 08:00

Comerica - CMA Conference Calls
PETS
Today at 08:00

PetMed Express - PETS Conference Calls
BAC
Today at 08:30

Bank of America - BAC Conference Calls
LOGI
Today at 08:30

Logitech - LOGI Conference Calls
HAL
Today at 09:00

Halliburton - HAL Conference Calls
EPAC
Today at 09:00

Enerpac Tool Group Corp Firm Sponsored Meetings

N86 W12500 Westbrook Crossing, Menomonee Falls, WI
OACB
Today at 09:00

OAKTREE ACQUISITION CORP. II Firm Sponsored Meetings

New York, NY
Today at 09:00

Healthcare Industry Meetings
GS
Today at 09:30

Goldman Sachs - GS Conference Calls
Today at 10:00

Board of Directors Meeting Government Event

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $16.00-18.00 15.647M Shares
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares
Fri	No deals

View All Syndicate Announcements »

Lightspeed price target raised to C$67 from C$56 at RBC Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access